Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease
May 26, 2026
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
May 23, 2026
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
May 23, 2026
Fosun Pharma Announces 2025 Annual Results
May 18, 2026
Fosun Pharma’s Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
December 9, 2025
Fosun Pharma Announces 2025Q3 Financial Results
October 29, 2025